Dr. Benjamin A. Biebel, MD

Dr. Biebel practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.

Dr. Biebel's NPI, 1972517241, was assigned on July 29, 2006. Dr. Biebel graduated from USF Health Morsani College of Medicine in 1999. Dr. Biebel holds Florida license ME91147.

Dr. Biebel's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.

Dr. Biebel's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Dr. Biebel is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Biebel to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Biebel practices, 2 sites in all. Vendor and product names are available with a free account.

Diagnostic ultrasound is Dr. Biebel's primary specialty in the NPI Registry, under taxonomy code 2085U0001X. Dr. Biebel is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dr. Biebel is licensed in Florida.

CMS data shows 85 Medicare services from Dr. Biebel across 3 procedure codes in 2024, for 65 Medicare patients. Medicare paid $2,826 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 65 Medicare patients who saw Dr. Biebel in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Biebel's median patient age at 67, with 48% women.

In 2018, Dr. Biebel wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $49 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Biebel for performance year 2024, reported as part of a group. Dr. Biebel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Biebel, published from 2016 to 2018. 2018 was the busiest year, with 2. The most frequent topics are Embolization, Therapeutic, Radiopharmaceuticals and Yttrium Radioisotopes. Dr. Biebel has published most often in J Gastrointest Oncol. Dr. Biebel's most frequent co-authors are Bela Kis, MD, PhD, Jennifer Sweeney, MD and Junsung Choi, MD.

CMS Open Payments shows 59 general payments to Dr. Biebel from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Abbvie Inc. paid the most, $1,874.

Dr. Biebel graduated from USF Health Morsani College of Medicine in 1999. Dr. Biebel is a member of SIR.

Dr. Biebel is in network with 2 carriers, including Humana and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.